These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16271083)

  • 1. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
    Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
    Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
    Horie-Inoue K; Inoue S
    Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
    Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
    Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
    Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
    Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
    Guo ZL; Chen K; Wang XQ; Hu W
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid.
    Ito Y; Miyoshi E; Uda E; Yoshida H; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Cancer Lett; 2003 Oct; 200(2):161-6. PubMed ID: 14568170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase.
    Ito K; Suzuki T; Moriya T; Utsunomiya H; Sugawara A; Konno R; Sato S; Sasano H
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2721-7. PubMed ID: 11397877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue.
    Dai H; Zhao S; Xu L; Chen A; Dai S
    Oncol Rep; 2010 Mar; 23(3):795-9. PubMed ID: 20127022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathologic significance of the loss of BAF250a (ARID1A) expression in endometrial carcinoma.
    Zhang ZM; Xiao S; Sun GY; Liu YP; Zhang FH; Yang HF; Li J; Qiu HB; Liu Y; Zhang C; Kang S; Shan BE
    Int J Gynecol Cancer; 2014 Mar; 24(3):534-40. PubMed ID: 24557437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
    Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
    Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
    Lee MH; Lozano G
    Semin Cancer Biol; 2006 Jun; 16(3):225-34. PubMed ID: 16697215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.
    Martínez-Galán J; Torres B; Del Moral R; Muñoz-Gámez JA; Martín-Oliva D; Villalobos M; Núñez MI; Luna Jde D; Oliver FJ; Ruiz de Almodóvar JM
    Cancer Biol Ther; 2008 Jun; 7(6):958-65. PubMed ID: 18379196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.